🔎 Trials Near Me

Domov › Crohnova bolezen › Ohio › Cleveland

Klinične študije za Crohnova bolezen v Cleveland, OH

19 študij za Crohnova bolezen išče udeležence na lokacijah v Cleveland in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3
  • Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi stran
Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07852273

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Vključevanje udeležencevFaza 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi stran
Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328

Non-nutritive Sweeteners in Inflammatory Bowel Disease

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi stran
Starost 18–70 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07769437

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Cleveland Clinic - Cleveland /ID# 256453, Cleveland
Starost 2–17 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05995353

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Vključevanje udeležencevFaza 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi stran
Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07577843

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Vključevanje udeležencev
  • Cleveland Clinic, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07680283

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • UH Cleveland Medical Center /ID# 262188, Cleveland
Starost 2–17 · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Vključevanje udeležencevFaza 3
  • University Children's Clinic, Cleveland
  • Cleveland Clinic, Cleveland
Starost 2–17 · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Vključevanje udeležencevFaza 4
  • UH/Rainbow Babies and Children's Hospital, Cleveland
Starost 6–17 · Vsi spoli · Posodobljeno 27. maj 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Starost 2 in več · Vsi spoli · Posodobljeno 7. maj 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

Vključevanje udeležencevFaza 2/3
  • Cleveland Clinic Children's Hospital, Cleveland
Starost 6–22 · Vsi spoli · Posodobljeno 5. maj 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Vključevanje udeležencevFaza 3
  • University Hospitals Cleveland Medical Center, Cleveland
Starost 2–17 · Vsi spoli · Posodobljeno 5. maj 2026 · NCT04779320

Treatment of Moderate to Severe Refractory Crohn's Disease

Vključevanje udeležencevFaza 1/2
  • Cleveland Clinic, Cleveland
Starost 18–65 · Vsi spoli · Posodobljeno 10. dec. 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Vključevanje udeležencevOpazovalna študija
  • Cleveland Clinic Foundation, Cleveland
Starost 18 in več · Vsi spoli · Posodobljeno 12. nov. 2025 · NCT06670638

Študije za Crohnova bolezen v drugih mestih

Druge študije v Cleveland

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.